Acquisition leverage Kalderos has been acquired by Model N to expand 340B capabilities and gross-to-net revenue management, presenting a cross-sell opportunity to Model N customers seeking enhanced drug discount management and revenue integrity solutions.

Healthcare focus Position Kalderos as a healthcare technology platform specialized in drug discount management for pharmaceutical manufacturers, state Medicaid programs, and covered entities, aligning with buyers in payer, provider, and life sciences segments.

Strategic leadership Recent leadership appointments in product, strategy, and engineering signal a strong emphasis on product differentiation and scalable architecture, offering opportunities to pitch integrations, data pipelines, and analytics enhancements.

Tech stack fit Utilize familiarity with Google Ads, Apache Kafka, Kubernetes, MongoDB, and Marketo to propose targeted data infrastructure, real-time analytics, and marketing automation improvements for healthcare customers and channel partners.

Financial potential With substantial revenue and a mid-sized employee base, there is room to target expansion within existing customers of Model N and similar mid-to-large healthcare tech firms through upsell of expanded discount management modules and revenue integrity tools.